High expression of DOCK4 is closely related to invasive breast cancer and subsequent bone metastasis, making it a potentially useful biomarker to predict the risk of tumor bone metastasis (Westbrook et al., 2019). Here, DOCK4 is linked to invasive breast carcinoma.